KALV vs SNOW · rev $13.7M vs rev $1.55B
Kalvista Pharmaceuticals Inc (KALV) versus Snowflake Inc. (SNOW) — a side-by-side from cached financials, not a winner call.
Kalvista Pharmaceuticals Inc (KALV) is a biotechnology company listed on NASDAQ.
Snowflake Inc. (SNOW) is a software - application company listed on US. It is led by Sridhar Ramaswamy Ph.D..
Latest reported KALV revenue for 2025-09-30 was $13.7M. Net income was -$158.9M. KALV currently screens at market cap $1.44B.
Latest reported SNOW revenue for 2026-07-31 was $1.55B. Net income was -$191.7M. Revenue was up 11.2% from 2026-04-30 to 2026-07-31. SNOW currently screens at market cap $73.90B.
KALV currently screens at market cap $1.44B. SNOW currently screens at market cap $73.90B.
Not investment advice. Open the KALV and SNOW stock pages for the full models.
Not investment advice.